Food Safety Incidents

Inaccurate Labeling has been detected in Symphytum stannum homeopathic ampules.

Written by SGS Digicomply Editorial Team | Nov 29, 2025 11:00:00 PM
Food Safety Incident: Inaccurate Labeling of Homeopathic Ampules

On November 18, 2025, an incident involving inaccurate labeling was reported concerning homeopathic ampules containing symphytum stannum. This issue was identified in the United States of America and has been categorized under control and labeling hazards.

Labeling accuracy is a critical aspect of food safety, as it ensures that consumers are well-informed about the products they are using. Inaccurate labeling can lead to potential health risks, particularly for individuals who may have allergies or sensitivities to certain ingredients. It is essential for all food-related products, including dietary supplements, to provide precise information regarding their contents.

The U.S. Food and Drug Administration (FDA) has emphasized the importance of compliance with labeling regulations to protect consumer health. In this case, the inaccurate labeling of the homeopathic ampules raises concerns about the safety and efficacy of the product. Consumers are advised to exercise caution and consult healthcare professionals before using any homeopathic or dietary supplement products that may be affected by this labeling issue.

As this situation develops, it is crucial for consumers to stay informed about the products they purchase and to report any discrepancies in labeling to the appropriate authorities. Ensuring food safety is a shared responsibility that requires vigilance from both consumers and manufacturers.

  • Incident: Inaccurate Labeling has been detected in Symphytum stannum homeopathic ampules.
  • Date: 2025-11-18
  • Product: Symphytum stannum homeopathic ampules
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: United States of America
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Hazard Category: Labelling
  • Source: U.S. Food and Drug Administration